Skip to content

Detection of Minimal Change Esophagitis by I-scan

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01560910
Enrollment
48
Registered
2012-03-22
Start date
2010-01-31
Completion date
2010-12-31
Last updated
2012-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastro-esophageal Reflux Disease, Non-erosive Reflux Disease

Keywords

with or without GERD symptoms, presenting to gastrointestinal clinic of Maharaj Nakorn Chiangmai Hospital, November 2009 to November 2010, GERD, NERD

Brief summary

Study design and objective The primary outcome of this prospective cohort study was to identify the endoscopic findings that have diagnostic value for the prediction of NERD (minimal change esophagitis) by using HD endoscopy with i-scan. The secondary outcome was to evaluate the response to proton pump inhibitor (PPI) in GERD patients with or without minimal change esophagitis.

Detailed description

Background and aims Majority of patients with gastro-esophageal reflux disease (GERD) were non-erosive reflux disease (NERD). High definition (HD) endoscopy with i-scan could enhance visualization of mucosal and vascular pattern and might identify changes that were invisible at standard endoscopy. This study aimed to evaluate the endoscopic findings that may have diagnostic value for the prediction of NERD by using HD endoscopy with i-scan. Methods Patients with typical GERD symptoms and healthy control without GERD symptoms were included and 2 validated GERD questionnaires were completed. The endoscopist was blinded to the presence of reflux symptoms and distal esophagus was examined using standard white light endoscopy followed by i-scan. Mucosal morphology at squamocolumnar junction (SCJ) observed by i-scan were compared between GERD patients and controls.

Interventions

None listed

Sponsors

arpa pungrasamee
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

18 to 80 years of age and had ability to provide written informed consent

Exclusion criteria

1. pregnancy, 2. cirrhosis or presence of gastroesophageal varices, 3. gastrointestinal hemorrhage, 4. angina pectoris, 5. allergy to PPI, 6. high risk or contraindication for endoscopy, 7. chronic cough,laryngitis, asthma.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026